Cancel
Armand Girard
Chief Business Officer
@
Venatorx Pharmaceuticals
42598s@ppz4wjhu.yzb
Sign up to see email
See Linkedin
Known information
- Has over 25 years of experience in strategic planning, corporate development, clinical development, and business development.
- Has extensive partnering experience, having completed collaborations, licenses, acquisitions, and spinouts by and between leading pharmaceutical and biotech companies.
- Joined Venatorx from GlycoMimetics where he was the Chief Business Officer.
- At GlycoMimetics, was responsible for corporate strategy, partnering, and managing the company’s corporate and institutional alliances supporting the development of uproleselan.
- Previously worked as Vice President, Technical Assessment and Senior Director for Business Development at Shire Pharmaceuticals.
- Worked to build the product pipeline and support Shire’s strategic venture arm through investments.
- Received an undergraduate degree from Lehigh University.
- Earned an MBA from St Joseph’s Haub School of Business Executive Pharmaceutical Marketing Program.
About Venatorx Pharmaceuticals
Venatorx Pharmaceuticals, founded in June 2010, focuses on developing novel anti-infectives to treat multi-drug-resistant bacterial and hard-to-treat viral infections. Their lead asset, cefepime-taniborbactam, has completed a Phase 3 study for complicated urinary tract infections and is under FDA review.
Report inaccurate information
